Palace Hotel
San Francisco, CA
Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.
Join medical device and digital health entrepreneurs, CEOs of venture-backed companies, and business development executives from large Medtech companies, as well as angels, venture capitalists, and corporate investors, for a dynamic two days of networking and presentations that can help you craft a winning strategy.
Please visit the event website for more information and check back in the coming weeks for registration to open.
Shelly Jackson
shelly.jackson@wsgr.comBrian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
Hin Au is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Hin provides IP strategy and counseling services to clients in a wide range of technical fields, including MedTech, digital health, biotech, medical/diagnostic devices, software, robotics, autonomous vehicle technologies, and clean energy. He has assisted many clients with building their patent portfolios and securing key strategic patents. Hin has hands-on engineering industry experience, having previously worked as an R&D engineer for six years at large U.S. semiconductor corporations. A native of Singapore, Hin is also fluent in Mandarin and Cantonese.
Haley Bavasi is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she focuses primarily on advising digital health companies across a range of privacy, transactional, research, and healthcare regulatory issues. In particular, Haley leverages her expertise in the Health Insurance Portability and Accountability Act (HIPAA), the U.S. federal health-privacy law, to provide early-stage companies with practical day-to-day counseling, as well advise as in the context of complex commercial transactions, M&A, and go-to-market strategy. Haley’s extensive experience with a wide range of cutting-edge digital health companies provides her with valuable market insights she leverages for her clients.
Jason Breen is a partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati, where he represents public and private companies at all stages of growth in M&A transactions, primarily working with clients in the life sciences and technology industries. Jason also represents venture capital, growth equity, and private equity funds and focuses on other strategic transactions, including divestitures, joint ventures, and financings.
Matt is primary outside IP counsel to more than 50 life sciences companies in Southern California.
Kassandra K. Castillo practices corporate and securities law in the San Diego office of Wilson Sonsini Goodrich & Rosati, where she serves as outside general counsel and advises life sciences and technology companies at all stages of development. She works closely with entrepreneurs to counsel them through initial company formation issues, day-to-day corporate governance matters, venture capital financing transactions, and liquidity events. She also counsels venture capital funds on structuring and executing investment transactions and managing their existing portfolio companies.
Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.
Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.
James advises life sciences and tech companies on a wide variety of matters and has extensive experience working with venture capital firms and other investors in private equity and debt financings.
Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is part of the firm’s digital health industry group and its healthcare practice. During the last 10 years, Andrea has focused her practice on healthcare law and amassed substantial experience representing clients in healthcare regulatory matters related to digital health and healthcare IT. Her clients include healthcare technology start-ups and industry investors, as well as healthcare systems, providers, payers, and facilities with digital health initiatives.
Maneesha Mithal is a partner in the Washington, D.C., office of Wilson Sonsini and co-chair of the firm’s privacy and cybersecurity practice. Maneesha advises clients on privacy, cybersecurity, and consumer protection matters and represents companies in regulatory investigations. She is also one of the founding members of Wilson Sonsini’s AI group.
Philip focuses primarily on the representation of medical device, biotechnology, pharmaceutical, diagnostic, and digital health companies in corporate governance, IPO, M&A, public company reporting, and private equity and debt financing matters.
Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.
Maya focuses on strategic patent counseling for healthcare and other technology-driven companies.
Marty represents innovative life sciences and technology clients in corporate transactions and governance matters.
Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations.